Form 8-K - Current report:
SEC Accession No. 0001140361-20-014355
Filing Date
2020-06-19
Accepted
2020-06-19 17:01:44
Documents
15
Period of Report
2020-06-19
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nt10012941x2_8k.htm   iXBRL 8-K 34051
2 EXHIBIT 1.2 nt10012941x2_ex1-2.htm EX-1.2 22089
3 EXHIBIT 5.1 nt10012941x2_ex5-1.htm EX-5.1 8837
7 nt10012941x2_ex5-1logo.jpg GRAPHIC 28720
  Complete submission text file 0001140361-20-014355.txt   252003

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA mgnx-20200619.xsd EX-101.SCH 4204
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mgnx-20200619_lab.xml EX-101.LAB 22718
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mgnx-20200619_pre.xml EX-101.PRE 16222
14 EXTRACTED XBRL INSTANCE DOCUMENT nt10012941x2_8k_htm.xml XML 4070
Mailing Address 9704 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9704 MEDICAL CENTER DRIVE Rockville MD 20850 301-251-5172
MACROGENICS INC (Filer) CIK: 0001125345 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36112 | Film No.: 20976400
SIC: 2834 Pharmaceutical Preparations